Jason Tardio
Vermögen: 18 715 $ am 31.05.2026
Vermögen: 18 715 $ am 31.05.2026
Mr. Jason Tardio is a President & Chief Operating Officer at Immunic, Inc. Mr. Tardio was previously employed as a Chief Operating Officer by Ovid Therapeutics, Inc., a VP & Head-Multiple Sclerosis Franchise by Novartis, Inc., and a General Manager & Managing Director by Biogen, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNIC, INC. 0.01% | 26.05.2026 | 1’251 ( 0.01% ) | 18 715 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNIC, INC. | Präsident | 12.07.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| OVID THERAPEUTICS INC. | Geschäftsführer | 11.07.2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01.11.2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01.09.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen